SMia€™s 16th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research. Aimed at an audience of senior specialists in neurology, CNS, clinical sciences and pharmacology, Pain Therapeutics 2016 will keep attendees at the forefront of scientific breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery. Presentations from a selection of leading pharmaceutical companies currently developing novel analgesic treatments including Glenmark, Pfizer, GSK, Grunenthal and Nektar Pharmaceuticals, will provide delegates with an understanding on key topics such as drug development mechanisms, neuropathic pain, severe chronic pain, sodium channels, industry challenges, plus much more! An interactive panel discussion on medical incidents in experimental clinical trials will be just one of the highlights at the conference this spring.
|Attending this conference||0|
|Not attendind this conference||0|
Are you attending this conference ?